RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      MTA1 Overexpression Induces Cisplatin Resistance Innasopharyngeal Carcinoma by Promoting Cancer Stem Cells Properties

      한글로보기

      https://www.riss.kr/link?id=A104830052

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The metastasis-associated gene 1 (MTA1) oncogene hasbeen suggested to be involved in the regulation of cancer progression. However, there is still no direct evidence that MTA1 regulates cisplatin (CDDP) resistance, as well as cancer stem cell properti...

      The metastasis-associated gene 1 (MTA1) oncogene hasbeen suggested to be involved in the regulation of cancer progression. However, there is still no direct evidence that MTA1 regulates cisplatin (CDDP) resistance, as well as cancer stem cell properties. In this study, we found that MTA1 was enriched in CNE1/CDDP cells. Knock down of MTA1 in CNE1/CDDP cells reversed CSCs properties and CDDP resistance. However, ectopic expression of MTA1 in CNE1 cells induced CSCs phenotypes and CDDP insensitivity. Interestingly, ectopic overexpression of MTA1-induced CSCs properties and CDDP resistance were reversed in CNE1 cells after inhibition of PI3K/Akt by LY294002. In addition, MTA1 expression and Akt activity in CNE1/CDDP cells was much higher than that in CNE1 cells. These results suggested that MTA1 may play a critical role in promoting CDDP resistance in NPC cells by regulatingcancer stem cell properties via thePI3K/Akt signaling pathway. Our findings suggested that MTA1 may be a potential target for overcoming CDDP resistance in NPC therapy.

      더보기

      참고문헌 (Reference)

      1 Liu, A. Y., "Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24" 35 : 537-545, 2014

      2 Ma, B. B., "The activity of mTOR inhibitor RAD001(everolimus)in nasopharyngeal carcinoma and cisplatin-resistant cell lines" 28 : 413-420, 2010

      3 Godwin, P., "Targeting nuclear factor-kappa B to overcome resistance to chemotherapy" 3 : 120-, 2013

      4 Venkatesha, V. A., "Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition" 14 : 519-525, 2012

      5 Li, Y., "Screening of anti-cancer agent using zebrafish : comparison with the MTT assay" 422 : 85-90, 2012

      6 Serin, M., "Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas" 38 : 1031-1035, 1999

      7 Spano, J. P., "Nasopharyngeal carcinomas : an update" 39 : 2121-2135, 2003

      8 Bui-Nguyen, T. M., "NFkappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx" 29 : 1179-1189, 2010

      9 Donnenberg, V. S., "Multiple drug resistance in cancer revisited : the cancer stem cell hypothesis" 45 : 872-877, 2005

      10 Li, D. Q., "Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer" 72 : 387-394, 2012

      1 Liu, A. Y., "Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24" 35 : 537-545, 2014

      2 Ma, B. B., "The activity of mTOR inhibitor RAD001(everolimus)in nasopharyngeal carcinoma and cisplatin-resistant cell lines" 28 : 413-420, 2010

      3 Godwin, P., "Targeting nuclear factor-kappa B to overcome resistance to chemotherapy" 3 : 120-, 2013

      4 Venkatesha, V. A., "Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition" 14 : 519-525, 2012

      5 Li, Y., "Screening of anti-cancer agent using zebrafish : comparison with the MTT assay" 422 : 85-90, 2012

      6 Serin, M., "Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas" 38 : 1031-1035, 1999

      7 Spano, J. P., "Nasopharyngeal carcinomas : an update" 39 : 2121-2135, 2003

      8 Bui-Nguyen, T. M., "NFkappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx" 29 : 1179-1189, 2010

      9 Donnenberg, V. S., "Multiple drug resistance in cancer revisited : the cancer stem cell hypothesis" 45 : 872-877, 2005

      10 Li, D. Q., "Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer" 72 : 387-394, 2012

      11 Reddy, S. D., "Metastasis-associated protein 1/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function" 287 : 27843-27850, 2012

      12 Kumar, R., "Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells" 70 : 6598-6608, 2010

      13 Salot, S., "MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines" 49 : 492-499, 2013

      14 Song, Q., "MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo" 32 : 54-, 2013

      15 Morais, C., "Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma" 15 : 412-425, 2010

      16 Singh, S. K., "Identification of a cancer stem cell in human brain tumors" 63 : 5821-5828, 2003

      17 Barr, M. P., "Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature" 8 : e54193-, 2013

      18 Kumar, R., "Emerging roles of MTA family members in human cancers" 30 : 30-37, 2003

      19 Nagaraj, S. R., "Crosstalk between VEGF and MTA1 signaling pathways contrib ute to aggressiveness of breast carcinoma" 2013

      20 Ma, L., "Cancer stem-like cell properties are regulated by EGFR/AKT/beta-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma" 280 : 2027-2041, 2013

      21 Shafee, N., "Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors" 68 : 3243-3250, 2008

      22 Vinogradov, S., "Cancer stem cells and drug resistance : the potential of nanomedicine" 7 : 597-615, 2012

      23 Zhang, Y., "Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation" 13 : 1924-1935, 1999

      24 Wang, H., "Acquisition of epithelialmesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/beta-catenin/Snail signaling pathway" 723 : 156-166, 2014

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2012-11-07 학술지명변경 한글명 : 분자와 세포 -> Molecules and Cells KCI등재
      2008-01-01 평가 SCI 등재 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 2.77 0.19 1.85
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.37 1.11 0.379 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼